A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks

Summary

Several observational studies have shown improvement in episodic migraine with the use of greater occipital nerve block as an acute therapy, and a recent placebo controlled trial did not show a decrease in frequency of episodic or chronic migraine; however, there has never been a placebo controlled trial to investigate the efficacy of GONB as an acute treatment for headache, and there has been no determination of guidelines for selection of patients who would be most likely to respond to GONB. In light of the above, the investigators propose a double-blind, placebo-controlled, randomized trial examining the use of GONB with lidocaine/bupivocaine in patients with an acute episodic migraine. The results of this trial are expected to guide more appropriate therapeutic management of these participants and the optimal use of this procedure. 50 subjects will be entered into this study. This study is being conducted at Thomas Jefferson University only.

Timeline

Start

2017-05-01

Primary completion

2017-12-31

Completion

2018-06-30

Outcome

Outcome not reported

Stopped (Enrollment): “Project never started - lack of resources and no subjects enrolled”

Drugs

Indications